Atea Pharmaceuticals
AVIR
$3.96
Share price
3.39%
Change (1 day)
18.92%
Change (1 year)
Categories
Atea Pharmaceuticals (AVIR) - Cash on Hand
Cash on Hand as of December 2023 : $0.57 B
According to Atea Pharmaceuticals's latest financial reports the company has $0.57 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Atea Pharmaceuticals - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.57 B | -10.61% |
| 2022-12-31 | $0.64 B | -15.39% |
| 2021-12-31 | $0.76 B | -10.09% |
| 2020-12-31 | $0.85 B | 3824.64% |
| 2019-12-31 | $21.66 M | -37.2% |
| 2018-12-31 | $34.49 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -63.99% | 🇺🇸 USA |